Citadel Advisors’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$922K Buy
+23,900
New +$993K ﹤0.01% 7849
2025
Q4
Sell
-54,500
Closed -$2.67M 14616
2025
Q3
$2.67M Sell
54,500
-220,900
-80% -$11.6M ﹤0.01% 5509
2025
Q2
$14.3M Buy
+275,400
New +$11.1M ﹤0.01% 2580

Other funds holding HNGE

Citadel Advisors's HNGE Position: Q1 2026 in Review

Citadel Advisors increased its Hinge Health (HNGE) stake by 114% in Q1 2026, buying an estimated $24M and bringing the position to 1,083,715 shares worth $41.8M. The position accounts for 0.01% of the portfolio, ranked #1528.

Citadel Advisors first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Citadel Advisors held 1,083,715 shares of Hinge Health worth $41.8M as of Q1 2026.
  • Citadel Advisors bought 577,611 Hinge Health shares in Q1 2026, an estimated $24M.
  • Hinge Health made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1528 holding.
  • Citadel Advisors first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.